Podcast: Hear an interview with our conference advisor
Dr. Sven Stegemann, Director Global Pharmaceutical Business Development,
Capsugel NV, Pfizer, Germany

Press Release
After efficiently discussing poory soluble compounds in the previous years we found a growing demand for new technologies and methods for 2010 as 60% of the compounds are still hardly soluble.

When poor solubility becomes an issue From early stage to proof of concept
S. Stegemann, F. Leveiller, D. Franchi, H. de Jong, H. Linden,
European Journal of Pharmaceutical Sciences

New Method for the Effective Production of Ultrafine Drug Nanocrystals
Jan Möschwitzer and Rainer H. Müller, Department of Pharmaceutical Technology, Biotechnology and Quality Management, Free University of Berlin, Berlin, Germany

Self-Emulsifying Drug Delivery Systems for Enhanced Bioavailability of Poorly Water-Soluble Drugs
Jean Cuiné, Pharm D, PhD Principal Scientist/Project Leader Pharmaceutical and Analytical Development, Novartis Pharma AG

How to evaluate formulation strategies for efficient early phase development?
Jan Möschwitzer, Principal Scientist, CPD-PSA, Solvay Pharmaceuticals

Solid dispersions as strategy to improve solubility/ dissolution of poorly water soluble drugs
Teófilo Vasconcelos, Pharmaceutical Development – BIAL, Portugal